HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrent erythema multiforme: clinical features and treatment in a large series of patients.

Abstract
Recurrent erythema multiforme is an uncommon disorder. We have reviewed the clinical features and treatment of 65 patients with this condition. The mean number of attacks per year was six (range 2-24), and the mean duration of the disease was 9.5 years (range 2-36) reflecting its chronicity. The majority of patients had oral mucous membrane involvement (69%). In 46 patients (71%) the condition was precipitated by a preceding herpes simplex virus infection. Acyclovir was found to be the most useful first-line treatment, with 55% of patients deriving benefit from either continuous oral acyclovir or a patient-initiated 5-day oral course at the onset of herpes simplex virus infection. Of those failing to respond to acyclovir, a small proportion responded to dapsone. The most resistant patients (11) were treated with azathioprine, with complete disease suppression in all cases.
AuthorsJ K Schofield, F M Tatnall, I M Leigh
JournalThe British journal of dermatology (Br J Dermatol) Vol. 128 Issue 5 Pg. 542-5 (May 1993) ISSN: 0007-0963 [Print] England
PMID8504046 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulins
  • Dapsone
  • Azathioprine
  • Acyclovir
Topics
  • Acyclovir (administration & dosage)
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Azathioprine (administration & dosage)
  • Child
  • Child, Preschool
  • Chronic Disease
  • Dapsone (administration & dosage)
  • Drug Administration Schedule
  • Erythema Multiforme (complications, drug therapy)
  • Female
  • Herpes Simplex (complications)
  • Humans
  • Immunization, Passive
  • Immunoglobulins (administration & dosage)
  • Infant
  • Male
  • Middle Aged
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: